APOE ε4 carriers also display breakdown of the blood–brain barrier (Nation et al., 2019) in the hippocampus and parahippocampal cortex before the onset of cognitive impairment and independent of Aβ and tau pathology (Montagne et al., 2020). The gene discussed is APOE; the disease is Cognitive impairment.